Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: J Heart Lung Transplant. 2015 Oct 30;35(3):362–369. doi: 10.1016/j.healun.2015.10.028

Table 1. Baseline Characteristics of Heart Transplant Recipients.

Variable N Age 18-59 N Age 60-69 N Age ≥70 P-
value1
Characteristic
Gender, Male, No (%) 36,190 27,030 (74.7) 13,527 11,178 (82.6) 715 644 (90.1) <.001
Race, White, No (%) 36,163 26,860 (74.3) 13,522 11,359 (84.0) 715 623 (87.1) <.001
Ischemic etiology, No (%) 36,189 8,449 (23.4) 13,526 6,067 (44.9) 715 383 (53.6) <.001
Creatinine (mg/dL), median (25th, 75th) 2 24,866 1.2 (0.9, 1.5) 10,682 1.3 (1.0, 1.6) 665 1.3 (1.1, 1.6) <.001
eGFR (ml/min per 1.73 m2), median (25th, 75th) 2 24,864 68.4 (52.0,
88.0)
10,681 58.9 (45.0,
72.3)
665 56.9 (45.1,
69.6)
<.001
CKD stage ≥3, No (%) 2 24,864 8,714 (35.1) 10,681 6,022 (56.4) 665 408 (61.4) <.001
Condition at time of transplant, No (%) 36,081 13,483 709 <.001
 Not hospitalized 16,409 (45.5) 6,619 (49.1) 390 (55.0)
 Hospitalized, not in intensive care unit 5,187 (14.4) 1,884 (14.0) 96 (13.5)
 In intensive care unit 14,485 (40.2) 4,980 (36.9) 223 (31.5)
History, No (%)
Diabetes 2 25,788 11,100 688 <.001
 Type II 2,085 (8.1) 1,650 (14.9) 112 (16.3)
 Type I 353 (1.4) 190 (1.7) 10 (1.5)
 Type Unknown 2,543 (9.9) 1,245 (11.2) 37 (5.4)
 Type Other 36 (0.1) 16 (0.1) 0
 Diabetes status unknown 335 (1.4) 142 (1.3) 12 (1.7)
 No 20,416 (79.2) 7,857 (70.8) 517 (75.2)
Hypertension 3 16,787 5,871 (36.2) 6,502 2,729 (43.9) 279 110 (40.7) <.001
Cerebrovascular disease 3 16,888 609 (3.6) 6,533 279 (4.3) 282 11 (3.9) 0.02
Peripheral vascular disease 3 16,833 509 (3.1) 6,524 297 (4.8) 280 11 (4.1) <.001
Chronic obstructive pulmonary disease 3 16,913 454 (2.8) 6,548 286 (4.6) 281 7 (2.6) <.001
Any prior malignancy 2 25,186 1,053 (4.2) 10,859 801 (7.4) 673 59 (8.8) <.001
Prior cardiac surgery 4 2,606 1,341 105
 Coronary artery bypass grafting only 390 (15.0) 447 (33.3) 55 (52.4) <.001
 Valve replacement/repair only 164 (6.3) 84 (6.3) 5 (4.8)
 Other (including multiple surgeries) 2,052 (78.7) 810 (60.4) 45 (42.9)
Life Support at time of transplant, No (%)
Extra corporeal membrane oxygenation 5 24,301 143 (0.6) 10,592 39 (0.4) 681 3 (0.4) 0.01
Intra-aortic balloon pump 36,190 2,087 (5.8) 13,527 757 (5.6) 715 44 (6.2) 0.57
Prostaglandins 5 24,301 49 (0.2) 10,592 15 (0.1) 681 0 0.14
Intravenous inotropes 2 25,832 12,093 (46.8) 11,118 5,214 (46.9) 688 304 (44.2) 0.80
Inhaled Nitric Oxide 36,190 45 (0.1) 13,527 17 (0.1) 715 0 0.83
Ventilator 36,190 1,017 (2.8) 13,527 357 (2.6) 715 22 (3.1) 0.39
Ventricular assist device at time of transplant 4 11,557 5,623 461 <.001
 Left ventricular assist device 3,302 (28.6) 1,593 (28.3) 97 (21.0)
 Right ventricular assist device 34 (0.3) 16 (0.3) 1 (0.2)
 Left + Right ventricular assist devices 489 (4.2) 109 (1.9) 7 (1.5)
 Total artificial heart 153 (1.3) 45 (0.8) 1 (0.2)
 None 7,579 (65.6) 3,860 (68.7) 355 (77.0)
1

P-values are based on chi-square rank based group means score statistics for all categorical row variables and chi-square 1 df rank correlation statistics for all continuous/ordinal row variables.

2

Excludes patients registered before Apr 1, 1994

3

Excludes patients registered before Apr 1, 1994 and after Jan 1, 2007

4

Excludes patients registered before Jun 30, 2004

5

Excludes patients registered before Apr 1, 1995